-World Food Programme Global food prices have taken a worrying turn as drought in the United States causes grain prices to surge. In the latest episode of the Food Factor Podcast, we spoke with WFP’s Deputy Director of Food Security Analysis Arif Husain to find out what the third food-price shock in five years means for the fight against hunger. * What are the main factors behind rising food prices this year? The...
More »SEARCH RESULT
Total Matching Records found : 3868
Rural land may be classified to protect farm interest-Amiti Sen
-The Economic Times The rural development ministry has drawn up an ambitious plan to demarcate rural land depending on its use to ensure that fertile agricultural land is not used for industrial purpose. An inter-ministerial group that will include experts from the national remote sensing agency and the town and country planning organisation will work out a feasibility plan. "While passing by huge tracts of fields full of crops it is not unusual...
More »The return of the rain
-The Business Standard Cautious optimism about the revival of the monsoon A progressive improvement in the monsoon, after a dismal June that saw rainfall deficient by over 30 per cent, has eased some worries over kharif crop production. Since then the rainfall deficit has been halved to 15 per cent, dispelling fears of a situation as bad as in 2009, when severe drought lowered foodgrain production by seven per cent. In addition,...
More »Loss figure not sacrosanct, we are open to debate: CAG-Pradeep Thakur
-The Times of India The estimate of Rs 1.86 lakh crore mentioned in the CAG report on Coalgate as "windfall gains" to private players who bagged coal mines allocated by the government without bidding is not sacrosanct, according to senior sources in the auditing agency. "We have never claimed that our estimate is not open to debate," sources said, adding that even the expression "windfall gains" was not that of the auditor....
More »Lack of compensation norms for clinical trials results in exploitation of poor patients-Khomba Singh
-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »
